Skip to content

Observational study to search for factors that exacerbate the progression and prevention of lifestyle-related diseases through temporal observation of the 75g oral glucose tolerance test, gut microbiota analysis, and metabolites analysis.

Observational study to search for factors that exacerbate the progression and prevention of lifestyle-related diseases through temporal observation of the 75g oral glucose tolerance test, gut microbiota analysis, and metabolites analysis. - Observational study in Kumejima

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047289
Enrollment
200
Registered
2022-03-26
Start date
2018-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic syndrome, obesity, pre diabetes, insulin resistance

Interventions

None listed

Sponsors

University of the Ryukyus.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Participants were residents in Kumejima island over 20 years old

Exclusion criteria

Exclusion criteria: 1) severe renal dysfunction (eGFR < 30 ml/min/1.73 m2) 2) hepatic dysfunction (AST > 200 IU/L or ALT > 200 IU/L) 3) malignancy,pregnancy, 4) chronic diarrhea 5) severe illness requiring hospitalization and treatment

Design outcomes

Primary

MeasureTime frame
To search for factors that worsen the progression of lifestyle-related diseases and protective factors through the 75g oral glucose tolerance test, gut microbiota analysis, metabolites analysis, and questionnaire survey observation over time, and to evaluate their significance as early diagnostic markers and predictive markers of pathological progression.

Countries

Japan

Contacts

Public ContactTsugumi Uema

Graduate School of Medicine, University of the Ryukyus. Division of Endocrinology, Diabetes and Metabolism,Hematology, Rheumatology.

ma2.ky8.26@gmail.com098-895-1146

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026